Robertson DG - Search Results

1

Effect of dexamethasone on the metabonomics profile associated with phosphodiesterase inhibitor-induced vascular lesions in rats.

Slim RM, Robertson DG, Albassam M, Reily MD, Robosky L, Dethloff LA. Slim RM, et al. Among authors: robertson dg. Toxicol Appl Pharmacol. 2002 Sep 1;183(2):108-9. Toxicol Appl Pharmacol. 2002. PMID: 12387750

2

In vivo toxicity screening programs using metabonomics.

Robosky LC, Robertson DG, Baker JD, Rane S, Reily MD. Robosky LC, et al. Among authors: robertson dg. Comb Chem High Throughput Screen. 2002 Dec;5(8):651-62. doi: 10.2174/1386207023329932. Comb Chem High Throughput Screen. 2002. PMID: 12470262 Review.

3

Metabonomics in pharmaceutical discovery and development.

Robertson DG, Reily MD, Baker JD. Robertson DG, et al. J Proteome Res. 2007 Feb;6(2):526-39. doi: 10.1021/pr060535c. J Proteome Res. 2007. PMID: 17269709 Review.

4

Metabonomic evaluation of metabolic dysregulation in rats induced by PF 376304, a novel inhibitor of phosphoinositide 3-kinase.

Robertson DG, Datta K, Wells D, Egnash L, Robosky L, Manning M, Rohde C, Reily MD. Robertson DG, et al. Chem Res Toxicol. 2007 Dec;20(12):1871-7. doi: 10.1021/tx7002036. Epub 2007 Nov 15. Chem Res Toxicol. 2007. PMID: 18001061

5

Metabonomic assessment of vasculitis in rats.

Robertson DG, Reily MD, Albassam M, Dethloff LA. Robertson DG, et al. Cardiovasc Toxicol. 2001;1(1):7-19. doi: 10.1385/ct:1:1:07. Cardiovasc Toxicol. 2001. PMID: 12213993

6

Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.

Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, Keun H, Beckonert O, Ebbels TM, Reily MD, Robertson D, Stevens GJ, Luke P, Breau AP, Cantor GH, Bible RH, Niederhauser U, Senn H, Schlotterbeck G, Sidelmann UG, Laursen SM, Tymiak A, Car BD, Lehman-McKeeman L, Colet JM, Loukaci A, Thomas C. Lindon JC, et al. Toxicol Appl Pharmacol. 2003 Mar 15;187(3):137-46. doi: 10.1016/s0041-008x(02)00079-0. Toxicol Appl Pharmacol. 2003. PMID: 12662897

7

Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats.

Robosky LC, Wells DF, Egnash LA, Manning ML, Reily MD, Robertson DG. Robosky LC, et al. Among authors: robertson dg. Toxicol Sci. 2005 Sep;87(1):277-84. doi: 10.1093/toxsci/kfi214. Epub 2005 Jun 2. Toxicol Sci. 2005. PMID: 15933226

8

Communication regarding metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats.

Robosky LC, Wells DF, Egnash LA, Manning ML, Reily MD, Robertson DG. Robosky LC, et al. Among authors: robertson dg. Toxicol Sci. 2006 May;91(1):309. doi: 10.1093/toxsci/kfj134. Epub 2006 Feb 16. Toxicol Sci. 2006. PMID: 16484286 No abstract available.

9

Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III SK&F 95654 in the spontaneously hypertensive rat.

Zhang J, Herman EH, Robertson DG, Reily MD, Knapton A, Ratajczak HV, Rifai N, Honchel R, Blanchard KT, Stoll RE, Sistare FD. Zhang J, et al. Among authors: robertson dg. Toxicol Pathol. 2006;34(2):152-63. doi: 10.1080/01926230600588562. Toxicol Pathol. 2006. PMID: 16537294

10

Metabonomics in preclinical drug development.

Robertson DG, Reily MD, Baker JD. Robertson DG, et al. Expert Opin Drug Metab Toxicol. 2005 Oct;1(3):363-76. doi: 10.1517/17425255.1.3.363. Expert Opin Drug Metab Toxicol. 2005. PMID: 16863449 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters